These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 36468579)

  • 1.
    Paradiso A; Volpi M; Rinoldi C; Celikkin N; Contessi Negrini N; Bilgen M; Dallera G; Pierini F; Costantini M; Święszkowski W; Farè S
    Biomater Sci; 2023 May; 11(9):2988-3015. PubMed ID: 36468579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Organoid-on-a-chip and body-on-a-chip systems for drug screening and disease modeling.
    Skardal A; Shupe T; Atala A
    Drug Discov Today; 2016 Sep; 21(9):1399-1411. PubMed ID: 27422270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in liver organoids: model systems for liver disease.
    Lee J; Mun SJ; Shin Y; Lee S; Son MJ
    Arch Pharm Res; 2022 Jun; 45(6):390-400. PubMed ID: 35661984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo translational models for rare liver diseases.
    Haugabook SJ; Ferrer M; Ottinger EA
    Biochim Biophys Acta Mol Basis Dis; 2019 May; 1865(5):1003-1018. PubMed ID: 30075192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human Brain Organoid: A Versatile Tool for Modeling Neurodegeneration Diseases and for Drug Screening.
    Ma C; Seong H; Li X; Yu X; Xu S; Li Y
    Stem Cells Int; 2022; 2022():2150680. PubMed ID: 36061149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3D Engineering of Ocular Tissues for Disease Modeling and Drug Testing.
    Boutin ME; Hampton C; Quinn R; Ferrer M; Song MJ
    Adv Exp Med Biol; 2019; 1186():171-193. PubMed ID: 31654390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A fully automated high-throughput workflow for 3D-based chemical screening in human midbrain organoids.
    Renner H; Grabos M; Becker KJ; Kagermeier TE; Wu J; Otto M; Peischard S; Zeuschner D; TsyTsyura Y; Disse P; Klingauf J; Leidel SA; Seebohm G; Schöler HR; Bruder JM
    Elife; 2020 Nov; 9():. PubMed ID: 33138918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of porcine gastrointestinal organoid units as a potential in vitro tool for drug discovery and development.
    Olayanju A; Jones L; Greco K; Goldring CE; Ansari T
    J Appl Toxicol; 2019 Jan; 39(1):4-15. PubMed ID: 29893059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Emerging Role of Neuronal Organoid Models in Drug Discovery: Potential Applications and Hurdles to Implementation.
    Struzyna LA; Watt ML
    Mol Pharmacol; 2021 Apr; 99(4):256-265. PubMed ID: 33547249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Organoids of liver diseases: From bench to bedside.
    Wu LJ; Chen ZY; Wang Y; Zhao JG; Xie XZ; Chen G
    World J Gastroenterol; 2019 Apr; 25(16):1913-1927. PubMed ID: 31086460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Organoids in modelling infectious diseases.
    Shpichka A; Bikmulina P; Peshkova M; Heydari Z; Kosheleva N; Vosough M; Timashev P
    Drug Discov Today; 2022 Jan; 27(1):223-233. PubMed ID: 34418577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of expandable human pluripotent stem cell-derived hepatocyte-like liver organoids.
    Mun SJ; Ryu JS; Lee MO; Son YS; Oh SJ; Cho HS; Son MY; Kim DS; Kim SJ; Yoo HJ; Lee HJ; Kim J; Jung CR; Chung KS; Son MJ
    J Hepatol; 2019 Nov; 71(5):970-985. PubMed ID: 31299272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microfluidic organ-on-a-chip models of human liver tissue.
    Moradi E; Jalili-Firoozinezhad S; Solati-Hashjin M
    Acta Biomater; 2020 Oct; 116():67-83. PubMed ID: 32890749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver microphysiological platforms for drug metabolism applications.
    Kulsharova G; Kurmangaliyeva A
    Cell Prolif; 2021 Sep; 54(9):e13099. PubMed ID: 34291515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Organ-on-chip models: Implications in drug discovery and clinical applications.
    Mittal R; Woo FW; Castro CS; Cohen MA; Karanxha J; Mittal J; Chhibber T; Jhaveri VM
    J Cell Physiol; 2019 Jun; 234(6):8352-8380. PubMed ID: 30443904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fitting tissue chips and microphysiological systems into the grand scheme of medicine, biology, pharmacology, and toxicology.
    Watson DE; Hunziker R; Wikswo JP
    Exp Biol Med (Maywood); 2017 Oct; 242(16):1559-1572. PubMed ID: 29065799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging Brain-Pathophysiology-Mimetic Platforms for Studying Neurodegenerative Diseases: Brain Organoids and Brains-on-a-Chip.
    Bang S; Lee S; Choi N; Kim HN
    Adv Healthc Mater; 2021 Jun; 10(12):e2002119. PubMed ID: 34028201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioengineering Liver Organoids for Diseases Modelling and Transplantation.
    Li J; Chu J; Lui VCH; Chen S; Chen Y; Tam PKH
    Bioengineering (Basel); 2022 Dec; 9(12):. PubMed ID: 36551002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Harnessing the Biology of Canine Intestinal Organoids to Heighten Understanding of Inflammatory Bowel Disease Pathogenesis and Accelerate Drug Discovery: A One Health Approach.
    Kopper JJ; Iennarella-Servantez C; Jergens AE; Sahoo DK; Guillot E; Bourgois-Mochel A; Martinez MN; Allenspach K; Mochel JP
    Front Toxicol; 2021; 3():773953. PubMed ID: 35295115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Organoid engineering with microfluidics and biomaterials for liver, lung disease, and cancer modeling.
    Kim SK; Kim YH; Park S; Cho SW
    Acta Biomater; 2021 Sep; 132():37-51. PubMed ID: 33711526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.